10 mg 90片瓶装阿托伐他汀仿制药被召回

美国食品药品管理局(FDA)宣布，已开始召回超过64,000瓶10 mg阿托伐他汀仿制药片剂。

这次全国性召回涉及64,626瓶阿托伐他汀仿制药，每瓶含90片。这些药物是由Ranbaxy制药公司生产的。发起召回的原因是，在1瓶密封的90片装10 mg阿托伐他汀仿制药中发现了1片20 mg阿托伐他汀片剂。

本次召回是由生产商Ranbaxy主动发起的，从2014年1月份开始。阿托伐他汀专利药的商品名为立普妥。

爱思唯尔版权所有  未经授权请勿转载

By: ELIZABETH MECHCATIE, Cardiology News Digital Network

More than 64,000 bottles of 10-mg generic atorvastatin tablets have been recalled, according to a notice on the Food and Drug Administration website.

The nationwide recall applies to 64,626 bottles that contain 90 tablets, and are manufactured by Ranbaxy Pharmaceuticals. The discovery of a 20-mg atorvastatin tablet in a sealed 90-count bottle of atorvastatin 10-mg tablets was the basis of the recall.

The recall is voluntary and was initiated by Ranbaxy in January 2014.

The affected bottles are pharmacy dispensing bottles, a Ranbaxy spokesperson said.

Lipitor is the brand-name version of atorvastatin.

---------------------------------------------------------------------------------------------------------------------------------------------
欢迎关注Elseviermed官方微信